Table 2.
Baseline demographic and disease characteristics of patients by Child-Pugh (CP) status
| Baseline characteristic* | CP A (n = 98) | CP B (n = 38) |
|---|---|---|
| Age (years) | ||
| Median | 70.0 | 67.5 |
| Range | 29–86 | 28–79 |
| Gender, n (%) | ||
| Male | 70 (71) | 26 (68) |
| Female | 28 (29) | 12 (32) |
| ECOG performance status, n (%) | ||
| 0 | 53 (54) | 15 (39) |
| 1 | 45 (46) | 23 (61) |
| AFP > upper limit of normal, n (%) | ||
| Yes | 76 (78) | 26 (68) |
| No | 13 (13) | 4 (11) |
| Unknown | 9 (9) | 8 (21) |
| Positive hepatitis status, n (%) | ||
| Hepatitis B | 20 (20) | 7 (18.4) |
| Hepatitis C | 41 (42) | 13 (34) |
| TNM stage at study entry, n (%) | ||
| I | 5 (5) | 2 (5) |
| II | 9 (9) | 1 (3) |
| IIIA/IIIB | 41 (42) | 11 (29) |
| IVA/IVB | 37 (38) | 20 (53) |
| Unknown | 6 (6) | 4 (10) |
AFP = alpha-fetoprotein; AJCC = American Joint Committee on Cancer; ECOG = Eastern Cooperative Oncology Group; TNM = tumor nodes metastasis.
*
One patient had missing data regarding Child-Pugh classification.